Showing results (201-210 of 216) with videos related to
Sort By:
Pageof 22
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinedionesKim M Hutchings, Tuan P Tran, Edmund L Ellsworth, et al.Journal of Medicinal Chemistry|January 6, 1999
Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptorB D Palmer, J B Smaill, M Boyd, et al.Journal of Medicinal Chemistry|November 7, 2000
3-(3,5-Dimethoxyphenyl)-1,6-naphthyridine-2,7-diamines and related 2-urea derivatives are potent and selective inhibitors of the FGF receptor-1 tyrosine kinaseA M Thompson, C J Connolly, J M Hamby, et al.Journal of Medicinal Chemistry|February 14, 1997
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congenersH D Showalter, A D Sercel, B M Leja, et al.Nature Chemical Biology|July 22, 2020
Structural insights into probe-dependent positive allosterism of the GLP-1 receptorAna B Bueno, Bingfa Sun, Francis S Willard, et al.Journal of Biomolecular Screening|August 17, 2011
Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein responseAndrew M Fribley, Patricia G Cruz, Justin R Miller, et al.Journal of Medicinal Chemistry|March 15, 2021
Discovery of an Orally Efficacious Positive Allosteric Modulator of the Glucagon-like Peptide-1 ReceptorFrancis S Willard, David B Wainscott, Aaron D Showalter, et al.Journal of Medicinal Chemistry|May 29, 1999
Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptorJ B Smaill, B D Palmer, G W Rewcastle, et al.JCI Insight|July 31, 2020
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistFrancis S Willard, Jonathan D Douros, Maria Bn Gabe, et al.Journal of Medicinal Chemistry|July 18, 1997
Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitorsJ M Hamby, C J Connolly, M C Schroeder, et al.Pageof 22